D

Daehan New Pharm Co Ltd
KOSDAQ:054670

Watchlist Manager
Daehan New Pharm Co Ltd
KOSDAQ:054670
Watchlist
Price: 6 580 KRW -0.6% Market Closed
Market Cap: 94.4B KRW

Operating Margin

6.5%
Current
Declining
by 3.3%
vs 3-y average of 9.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.5%
=
Operating Income
₩13.2B
/
Revenue
₩201.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.5%
=
Operating Income
₩13.2B
/
Revenue
₩201.6B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Daehan New Pharm Co Ltd
KOSDAQ:054670
92.4B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Korea
Percentile
69th
Based on 2 615 companies
69th percentile
6.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Daehan New Pharm Co Ltd
Glance View

Market Cap
94.4B KRW
Industry
Pharmaceuticals

Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-02-26. The firm provides two categories of products: human pharmaceutical products and animal pharmaceutical products. Its human pharmaceutical products include analgesics, anti-inflammatory drugs, antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics, immunosuppressants, cardiovascular drugs, gastrointestinal drugs, muscle relaxants, antispasmodics and others. Its animal pharmaceutical products include antibacterial, coccidiostats, antihelmintics, probiotic, nutrients, metabolic stimulants, disinfectants, functional supplement feeds, liver tonics, antihelmintics and others for poultries, cattle, sheep, swine and fishes.

Intrinsic Value
11 848.87 KRW
Undervaluation 44%
Intrinsic Value
Price
D
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.5%
=
Operating Income
₩13.2B
/
Revenue
₩201.6B
What is Daehan New Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Daehan New Pharm Co Ltd is 6.5%, which is below its 3-year median of 9.9%.

How has Operating Margin changed over time?

Over the last 3 years, Daehan New Pharm Co Ltd’s Operating Margin has decreased from 13.7% to 6.5%. During this period, it reached a low of 6.5% on Oct 30, 2025 and a high of 13.9% on Dec 31, 2022.

Back to Top